<?xml version="1.0" encoding="UTF-8"?>
<ref id="B164-pharmaceuticals-12-00147">
 <label>164.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Momose</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Basler</surname>
    <given-names>C.F.</given-names>
   </name>
   <name>
    <surname>Oâ€™Neill</surname>
    <given-names>R.E.</given-names>
   </name>
   <name>
    <surname>Iwamatsu</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Palese</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Nagata</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Cellular splicing factor RAF-2p48/NPI-5/BAT1/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis</article-title>
  <source>J. Virol.</source>
  <year>2001</year>
  <volume>75</volume>
  <fpage>1899</fpage>
  <lpage>1908</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.75.4.1899-1908.2001</pub-id>
  <pub-id pub-id-type="pmid">11160689</pub-id>
 </element-citation>
</ref>
